vs
礼蓝动物保健（ELAN）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
礼蓝动物保健的季度营收约是RANGE RESOURCES CORP的1.5倍（$1.1B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs -24.1%，领先46.9%），RANGE RESOURCES CORP同比增速更快（18.0% vs 12.2%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs -2.6%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
ELAN vs RRC — 直观对比
营收规模更大
ELAN
是对方的1.5倍
$786.9M
营收增速更快
RRC
高出5.8%
12.2%
净利率更高
RRC
高出46.9%
-24.1%
两年增速更快
RRC
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $786.9M |
| 净利润 | $-276.0M | $179.1M |
| 毛利率 | 51.5% | 94.5% |
| 营业利润率 | -22.6% | — |
| 净利率 | -24.1% | 22.8% |
| 营收同比 | 12.2% | 18.0% |
| 净利润同比 | -3350.0% | 88.8% |
| 每股收益（稀释后） | $-0.55 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANRRC
| Q4 25 | $1.1B | $786.9M | ||
| Q3 25 | $1.1B | $655.3M | ||
| Q2 25 | $1.2B | $699.6M | ||
| Q1 25 | $1.2B | $846.3M | ||
| Q4 24 | $1.0B | $667.0M | ||
| Q3 24 | $1.0B | $567.9M | ||
| Q2 24 | $1.2B | $513.2M | ||
| Q1 24 | $1.2B | $598.8M |
净利润ELANRRC
| Q4 25 | $-276.0M | $179.1M | ||
| Q3 25 | $-34.0M | $144.3M | ||
| Q2 25 | $11.0M | $237.6M | ||
| Q1 25 | $67.0M | $97.1M | ||
| Q4 24 | $-8.0M | $94.8M | ||
| Q3 24 | $364.0M | $50.7M | ||
| Q2 24 | $-50.0M | $28.7M | ||
| Q1 24 | $32.0M | $92.1M |
毛利率ELANRRC
| Q4 25 | 51.5% | 94.5% | ||
| Q3 25 | 53.4% | 92.5% | ||
| Q2 25 | 57.5% | 95.0% | ||
| Q1 25 | 57.3% | 93.1% | ||
| Q4 24 | 50.9% | 93.7% | ||
| Q3 24 | 52.2% | 94.3% | ||
| Q2 24 | 58.2% | 93.4% | ||
| Q1 24 | 57.3% | 94.7% |
营业利润率ELANRRC
| Q4 25 | -22.6% | — | ||
| Q3 25 | -4.4% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | -5.0% | — | ||
| Q3 24 | 54.3% | — | ||
| Q2 24 | -2.7% | — | ||
| Q1 24 | 1.0% | — |
净利率ELANRRC
| Q4 25 | -24.1% | 22.8% | ||
| Q3 25 | -3.0% | 22.0% | ||
| Q2 25 | 0.9% | 34.0% | ||
| Q1 25 | 5.6% | 11.5% | ||
| Q4 24 | -0.8% | 14.2% | ||
| Q3 24 | 35.3% | 8.9% | ||
| Q2 24 | -4.2% | 5.6% | ||
| Q1 24 | 2.7% | 15.4% |
每股收益（稀释后）ELANRRC
| Q4 25 | $-0.55 | $0.75 | ||
| Q3 25 | $-0.07 | $0.60 | ||
| Q2 25 | $0.02 | $0.99 | ||
| Q1 25 | $0.13 | $0.40 | ||
| Q4 24 | $-0.01 | $0.38 | ||
| Q3 24 | $0.73 | $0.21 | ||
| Q2 24 | $-0.10 | $0.12 | ||
| Q1 24 | $0.06 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $204.0K |
| 总债务越低越好 | $3.9B | $1.2B |
| 股东权益账面价值 | $6.5B | $4.3B |
| 总资产 | $13.4B | $7.4B |
| 负债/权益比越低杠杆越低 | 0.60× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资ELANRRC
| Q4 25 | $545.0M | $204.0K | ||
| Q3 25 | $505.0M | $175.0K | ||
| Q2 25 | $539.0M | $134.0K | ||
| Q1 25 | $487.0M | $344.6M | ||
| Q4 24 | $468.0M | $304.5M | ||
| Q3 24 | $490.0M | $277.4M | ||
| Q2 24 | $416.0M | $251.1M | ||
| Q1 24 | $345.0M | $343.1M |
总债务ELANRRC
| Q4 25 | $3.9B | $1.2B | ||
| Q3 25 | $4.0B | $1.2B | ||
| Q2 25 | $4.1B | $1.2B | ||
| Q1 25 | $4.4B | $1.7B | ||
| Q4 24 | $4.3B | $1.7B | ||
| Q3 24 | $4.4B | $1.7B | ||
| Q2 24 | $5.7B | $1.7B | ||
| Q1 24 | $5.8B | $1.8B |
股东权益ELANRRC
| Q4 25 | $6.5B | $4.3B | ||
| Q3 25 | $6.7B | $4.2B | ||
| Q2 25 | $6.8B | $4.1B | ||
| Q1 25 | $6.4B | $3.9B | ||
| Q4 24 | $6.1B | $3.9B | ||
| Q3 24 | $6.5B | $3.9B | ||
| Q2 24 | $5.9B | $3.9B | ||
| Q1 24 | $6.1B | $3.8B |
总资产ELANRRC
| Q4 25 | $13.4B | $7.4B | ||
| Q3 25 | $13.6B | $7.2B | ||
| Q2 25 | $13.7B | $7.1B | ||
| Q1 25 | $12.9B | $7.4B | ||
| Q4 24 | $12.6B | $7.3B | ||
| Q3 24 | $13.3B | $7.2B | ||
| Q2 24 | $13.8B | $7.3B | ||
| Q1 24 | $14.0B | $7.4B |
负债/权益比ELANRRC
| Q4 25 | 0.60× | 0.28× | ||
| Q3 25 | 0.59× | 0.29× | ||
| Q2 25 | 0.61× | 0.29× | ||
| Q1 25 | 0.69× | 0.43× | ||
| Q4 24 | 0.70× | 0.43× | ||
| Q3 24 | 0.67× | 0.44× | ||
| Q2 24 | 0.96× | 0.44× | ||
| Q1 24 | 0.95× | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $46.0M | — |
| 自由现金流率自由现金流/营收 | 4.0% | — |
| 资本支出强度资本支出/营收 | 5.4% | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | $284.0M | — |
8季度趋势，按日历期对齐
经营现金流ELANRRC
| Q4 25 | $108.0M | $257.5M | ||
| Q3 25 | $219.0M | $247.5M | ||
| Q2 25 | $237.0M | $336.2M | ||
| Q1 25 | $-4.0M | $330.1M | ||
| Q4 24 | $177.0M | $217.9M | ||
| Q3 24 | $162.0M | $245.9M | ||
| Q2 24 | $200.0M | $148.8M | ||
| Q1 24 | $2.0M | $331.9M |
自由现金流ELANRRC
| Q4 25 | $46.0M | — | ||
| Q3 25 | $127.0M | — | ||
| Q2 25 | $180.0M | — | ||
| Q1 25 | $-69.0M | — | ||
| Q4 24 | $130.0M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $166.0M | — | ||
| Q1 24 | $-22.0M | — |
自由现金流率ELANRRC
| Q4 25 | 4.0% | — | ||
| Q3 25 | 11.2% | — | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | -1.8% | — |
资本支出强度ELANRRC
| Q4 25 | 5.4% | — | ||
| Q3 25 | 8.1% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 2.0% | — |
现金转化率ELANRRC
| Q4 25 | — | 1.44× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | 21.55× | 1.42× | ||
| Q1 25 | -0.06× | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | 0.45× | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | 0.06× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
